PT Abadi Lestari Indonesia Tbk (RLCO) Reports Double-Digit Net Profit Growth in the First Half of 2026
PT Abadi Lestari Indonesia Tbk (RLCO) reported a 13.39% increase in net profit to Rp20.36 billion in the first half of 2026. The Company's positive performance was supported by strong sales of processed edible bird's nest products, disciplined cost management, asset growth, and continued investment in bioactive phytopharmaceutical product development.
Bojonegoro, July 31, 2026 – PT Abadi Lestari Indonesia Tbk (IDX: RLCO) recorded double-digit net profit growth in the first half of 2026 amid dynamic market conditions. As of June 30, 2026, the Company posted net profit attributable to owners of the parent entity of Rp20.36 billion, representing a 13.39% increase from Rp17.96 billion recorded in the same period last year.
President Director of PT Abadi Lestari Indonesia Tbk, Edwin Pranata, stated that the achievement reflects the Company's ability to maintain business performance, strengthen its financial fundamentals, and continuously develop its business in a sustainable manner.
"We are grateful to conclude the first half of 2026 with solid performance. This achievement motivates the Company to further strengthen its competitiveness through operational excellence, product innovation, and prudent, sustainable business management. We believe that consistently executing these strategies will create added value for our customers, business partners, and shareholders," said Edwin.
During the first half of 2026, the Company generated Rp272 billion in revenue, with processed edible bird's nest products remaining the primary contributor. Sales of processed edible bird's nest products reached Rp234.39 billion, accounting for approximately 86.2% of total revenue, while consumer products contributed Rp37.61 billion, representing around 13.8%.
In line with higher business activities, the Company's cost of goods sold amounted to Rp210.91 billion, resulting in a gross profit of Rp61.09 billion. The Company also maintained profitability through disciplined operational and financing cost management, while recording Rp437.80 million in interest income. Consequently, net profit for the period increased to Rp20.37 billion in the first half of 2026.
From a financial position perspective, the Company's total assets increased by 3.22% to Rp835.82 billion as of June 30, 2026, compared with Rp809.76 billion as of December 31, 2025. The increase was primarily driven by higher current assets, which reached Rp730.28 billion.
Total liabilities stood at Rp510.10 billion, slightly higher than Rp504.42 billion at the end of 2025. Meanwhile, long-term liabilities declined to Rp21.36 billion from Rp27.69 billion, while total equity increased by 6.67% to Rp325.71 billion from Rp305.34 billion at the end of the previous year, mainly supported by current period earnings.
From a liquidity standpoint, cash receipts from customers increased to Rp221.90 billion, compared with Rp200.13 billion in the first half of 2025. Investment activities during the period were primarily directed toward supporting business expansion, including investments in intangible assets.
As of June 30, 2026, intangible assets under development mainly consisted of bioactive phytopharmaceutical product testing, which had reached approximately 32% financial completion and is expected to be completed in 2027. This development reflects the Company's commitment to strengthening innovation and developing higher value-added products.
Through prudent financial management, the Company closed the first half of 2026 with Rp65.76 billion in cash and cash equivalents, providing sufficient liquidity to support ongoing operations and future business development.
About PT Abadi Lestari Indonesia Tbk
PT Abadi Lestari Indonesia Tbk is a holding company focused on the processing and development of high-quality protein products, with a vision to become a leading integrated protein industry player from Indonesia serving global markets. The Company develops its business through innovation, quality, and value creation to meet the needs of both domestic and international customers.
Through research, innovation, and high-standard production processes, the Company delivers modern health and nutrition products that are accessible to consumers while maintaining product purity and quality. By emphasizing innovation and sustainability, the Company is committed not only to business growth but also to contributing to improved nutrition, the development of Indonesia’s food industry, and the expansion of export markets for premium Indonesian protein products worldwide.
For Further Information
Ayu Amanda
Corporate Secretary
PT Abadi Lestari Indonesia Tbk
Email: [email protected]
Phone: +62 811-3624-247
Website: www.realco-ali.com